{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:39:28Z","timestamp":1790383168128,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ygyno.2019.08.032","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T08:19:54Z","timestamp":1567671594000},"page":"294-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER\u2013Medicare data"],"prefix":"10.1016","volume":"155","author":[{"given":"Kara A.","family":"Michels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"McNeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2019.08.032_bb0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.ygyno.2019.08.032_bb0010","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003\u20132012","volume":"313","author":"Aguilar","year":"2015","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ygyno.2019.08.032_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/emph\/eoz004","article-title":"Energy oversupply to tissues: a single mechanism possibly underlying multiple cancer risk factors","volume":"2019","author":"Wu","year":"2019","journal-title":"Evolution, Medicine, and Public Health"},{"issue":"19","key":"10.1016\/j.ygyno.2019.08.032_bb0020","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ygyno.2019.08.032_bb0025","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ije\/dyr130","article-title":"Metabolic risk factors and ovarian cancer in the metabolic syndrome and cancer project","volume":"40","author":"Bj\u00f8rge","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2019.08.032_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12986-017-0176-4","article-title":"Case-control study of metabolic syndrome and ovarian cancer in Chinese population","volume":"14","author":"Chen","year":"2017","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"3","key":"10.1016\/j.ygyno.2019.08.032_bb0035","first-page":"143","article-title":"Metabolic risk profile and cancer in Korean men and women","volume":"49","author":"Ko","year":"2016","journal-title":"J.\u00a0Prev. Med. Public Health"},{"issue":"12","key":"10.1016\/j.ygyno.2019.08.032_bb0040","first-page":"1107","article-title":"The association between overweight, obesity and ovarian cancer: a meta-analysis","volume":"45","author":"Liu","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.08.032_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/IGC.0b013e31828189b2","article-title":"Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies","volume":"23","author":"Lee","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8 Suppl","key":"10.1016\/j.ygyno.2019.08.032_bb0050","first-page":"Iv","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med. Care"},{"key":"10.1016\/j.ygyno.2019.08.032_bb0055","author":"Healthcare Delivery Research Progam"},{"key":"10.1016\/j.ygyno.2019.08.032_bb0060","author":"Healthcare Delivery Research Progam, Division of Cancer Control and Population Sciences, National Cancer Institute"},{"key":"10.1016\/j.ygyno.2019.08.032_bb0065","series-title":"Obesity and Cancer","first-page":"155","article-title":"Obesity and ovarian cancer","author":"Tworoger","year":"2016"},{"issue":"24","key":"10.1016\/j.ygyno.2019.08.032_bb0070","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.08.032_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/CEJ.0000000000000435","article-title":"Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women","volume":"27","author":"Kabat","year":"2018","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2019.08.032_bb0080","first-page":"13","article-title":"Serum lipids and risk of obesity-related cancers in postmenopausal women","volume":"29","author":"Kabat","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"8","key":"10.1016\/j.ygyno.2019.08.032_bb0085","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/1055-9965.EPI-12-0188","article-title":"Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study","volume":"21","author":"Melvin","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2019.08.032_bb0090","first-page":"291","article-title":"Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study","volume":"22","author":"Borena","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ygyno.2019.08.032_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijc.30066","article-title":"Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer","volume":"139","author":"Huang","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2019.08.032_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11886-017-0933-z","article-title":"Hypertension in African Americans","volume":"19","author":"Musemwa","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2019.08.032_bb0105","doi-asserted-by":"crossref","first-page":"e60308","DOI":"10.1371\/journal.pone.0060308","article-title":"Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001\u20132009","volume":"8","author":"Olives","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.ygyno.2019.08.032_bb0110","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2019.08.032_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1610001","article-title":"IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function","volume":"161","author":"Wang","year":"1999","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.ygyno.2019.08.032_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2017.08.012","article-title":"IGF system targeted therapy: therapeutic opportunities for ovarian cancer","volume":"60","author":"Liefers-Visser","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2019.08.032_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.maturitas.2016.08.012","article-title":"Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: a systematic review and meta-analysis","volume":"94","author":"Gianuzzi","year":"2016","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.ygyno.2019.08.032_bb0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2019.08.032_bb0135","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2019.08.032_bb0140","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2019.08.032_bb0145","unstructured":"Carroll M., Kit B., Lacher D. Trends in Elevated Triglyceride in Adults: United States, 2001\u20132012. NCHS Data Brief 2015; (198):198. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db198.pdf."},{"key":"10.1016\/j.ygyno.2019.08.032_bb0150","series-title":"Health, United States, 2010: With Special Feature on Death and Dying","first-page":"547","author":"National Center for Health Statistics","year":"2011"},{"issue":"4","key":"10.1016\/j.ygyno.2019.08.032_bb0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.21.4.518","article-title":"Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ygyno.2019.08.032_bb0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2105\/AJPH.2011.300616","article-title":"Aging, diabetes, and the public health system in the United States","volume":"102","author":"Caspersen","year":"2012","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.ygyno.2019.08.032_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11606-018-4310-4","article-title":"Trends in diabetes treatment and monitoring among Medicare beneficiaries","volume":"33","author":"Landon","year":"2018","journal-title":"J.\u00a0Gen. Intern. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819314842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819314842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:46:05Z","timestamp":1758771965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819314842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0090825819314842"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.08.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER\u2013Medicare data","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}